Thermo Fisher Scientific has announced plans to invest an additional $2 billion in the US over the next four years. The investment over the next four years includes: 

• $1.5 billion in capital expenditures to enhance and expand US manufacturing operations; and  

• A $500-million investment in R&D. 

The company has 64 US manufacturing operations, located in 37 states, making analytical instruments, specialty diagnostics, and life sciences products as well as providing contract development and manufacturing services.  

Since 2017, Thermo Fisher reports that it has more than doubled in size—from $21 billion in revenue and 28,000 US employees to $43 billion in revenue and more than 50,000 US employees currently (as reported on April 24, 2025). The company says it also invests $1 billion annually in R&D in the US.  

Source: Thermo Fisher Scientific